Skip to Content

Felodipine Pregnancy and Breastfeeding Warnings

Felodipine is also known as: Plendil

Medically reviewed on December 15, 2017

Felodipine Pregnancy Warnings

Animal studies have revealed evidence of fetolethality and fetotoxicity at doses greater than the maximum recommended human dose on a mg/m2 basis. There are no controlled data in human pregnancy.

AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

The manufacturer makes no recommendation regarding use during pregnancy; use is contraindicated per some authorities.

AU TGA pregnancy category: C
US FDA pregnancy category: C

Comments: If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential harm to the fetus.

See references

Felodipine Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Yes

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Plendil (felodipine)." Merck & Co, Inc, West Point, PA.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. "Product Information. Plendil (felodipine)." Merck & Co, Inc, West Point, PA.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide